Top compounds associated with response to BICDL1


Feature Type Standardized
Nominal ANOVA
mRNA pluripotin CTRPv2 pan-cancer AAC -0.2 5e-08
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.19 1e-07
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.17 2e-07
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.17 4e-06
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.17 6e-06
mRNA lovastatin CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.16 1e-05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.15 2e-05
Download CSV